Abdominal Infection
10
0
0
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
10%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
Management and Outcome of Mesh Infection After Abdominoplasty in a Tertiary Care Centre
A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis
Closed or Open Abdomen for the Management of Abdominal Sepsis
A Non-Traumatic Binder for Temporary Abdominal Wall Closure
Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative Infections
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery
Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock